The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Finn John since 2011.
The trader's CIK number is 1479788.
At the time of the last reporting, Finn John was the Chief Scientific Officer of Trius Therapeutics Inc. (stock ticker symbol TRSX).
Also see all insider trading activities at Trius Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | TSRX | 0 | $0 | 25,000 | $226,089 | 0 | $0 |
| 2012 | TSRX | 0 | $0 | 0 | $0 | 20,000 | $10,400 |
| 2011 | TSRX | 0 | $0 | 20,000 | $143,294 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-07-22 | TSRX | Sale | 1,000 | 12.10 | 12,100 |
| 2013-07-15 | TSRX | Sale | 3,500 | 10.55 | 36,925 |
| 2013-07-10 | TSRX | Sale | 1,000 | 8.58 | 8,580 |
| 2013-07-11 | TSRX | Sale | 500 | 9.32 | 4,660 |
| 2013-07-12 | TSRX | Sale | 5,000 | 10.10 | 50,500 |
| 2013-06-12 | TSRX | Sale | 3,000 | 9.08 | 27,249 |
| 2013-06-11 | TSRX | Sale | 1,000 | 8.94 | 8,940 |
| 2013-05-14 | TSRX | Sale | 5,000 | 8.10 | 40,510 |
| 2013-05-10 | TSRX | Sale | 3,000 | 7.47 | 22,425 |
| 2013-04-24 | TSRX | Sale | 500 | 7.10 | 3,550 |
| 2013-03-15 | TSRX | Sale | 1,500 | 7.10 | 10,650 |
| 2012-03-26 | TSRX | Option Ex | 20,000 | .52 | 10,400 |
| 2011-10-11 | TSRX | Sale | 500 | 6.19 | 3,095 |
| 2011-09-15 | TSRX | Sale | 1,000 | 6.47 | 6,470 |
| 2011-08-11 | TSRX | Sale | 200 | 7.00 | 1,400 |
| 2011-08-12 | TSRX | Sale | 300 | 7.00 | 2,100 |
| 2011-08-09 | TSRX | Sale | 1,000 | 5.91 | 5,910 |
| 2011-07-20 | TSRX | Sale | 500 | 8.00 | 4,000 |
| 2011-07-12 | TSRX | Sale | 1,500 | 7.23 | 10,845 |
| 2011-06-09 | TSRX | Sale | 2,000 | 8.09 | 16,187 |
| 2011-05-16 | TSRX | Sale | 7,000 | 8.02 | 56,161 |
| 2011-05-12 | TSRX | Sale | 1,500 | 7.00 | 10,500 |
| 2011-05-10 | TSRX | Sale | 1,000 | 6.02 | 6,018 |
| 2011-05-03 | TSRX | Sale | 800 | 6.00 | 4,800 |
| 2011-04-11 | TSRX | Sale | 500 | 5.36 | 2,678 |
| 2011-03-30 | TSRX | Sale | 200 | 6.00 | 1,200 |
| 2011-03-09 | TSRX | Sale | 500 | 5.86 | 2,930 |
| 2011-03-01 | TSRX | Sale | 500 | 7.00 | 3,500 |
| 2011-02-17 | TSRX | Sale | 500 | 5.00 | 2,500 |
| 2011-02-18 | TSRX | Sale | 500 | 6.00 | 3,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Finn John (Chief Scientific Officer of Trius Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.